Impact of Blood Vessel Quantity and Vascular Expression of CD133 and ICAM-1 on Survival of Glioblastoma Patients | Zendy

Ave Minajeva | Zendy; Marju Kase | Zendy; Mikk Saretok | Zendy; Aidi Adamson-Raieste | Zendy; Sandra Kase | Zendy; Kristi Niinepuu | Zendy; Markus Vardja | Zendy; Toomas Asser | Zendy; Jana Jaal | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Impact of Blood Vessel Quantity and Vascular Expression of CD133 and ICAM-1 on Survival of Glioblastoma Patients

Author(s) -

Ave Minajeva,

Marju Kase,

Mikk Saretok,

Aidi Adamson-Raieste,

Sandra Kase,

Kristi Niinepuu,

Markus Vardja,

Toomas Asser,

Jana Jaal

Publication year - 2017

Publication title -

neuroscience journal

Language(s) - English

Resource type - Journals

eISSN - 2314-4270

pISSN - 2314-4262

DOI - 10.1155/2017/5629563

Subject(s) - glioblastoma , icam 1 , blood vessel , pathology , medicine , cancer research , immunology , cell adhesion molecule

Glioblastoma (GB) is the most angiogenic tumor. Nevertheless, antiangiogenic therapy has not shown significant clinical efficacy. The aim of this study was to assess blood vessel characteristics on survival of GB patients. Surgically excised GB tissues were histologically examined for overall proportion of glomeruloid microvascular proliferation (MP) and the total number of blood vessels. Also, immunohistochemical vascular staining intensities of CD133 and ICAM-1 were determined. Vessel parameters were correlated with patients' overall survival. The survival time depended on the number of blood vessels ( p = 0.03) but not on the proportion of MP. Median survival times for patients with low (

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research